quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:12:36·1192d
NEWSRelease
Amryt Pharma plc logo

HC Wainwright & Co. Downgrades Amryt Pharma to Neutral

AMYT· Amryt Pharma plc
Health Care
Original source

Companies

  • AMYT
    Amryt Pharma plc
    Health Care

Recent analyst ratings

  • Sep 6UpdateCanaccord Genuity$19.00
  • Mar 10UpdateHC Wainwright & Co.$18.00
  • Mar 10UpdateSVB Leerink$10.00
  • Nov 23UpdateSVB Leerink$19.00
  • Oct 4UpdateJonesTrading$45.00
  • Aug 19UpdateSVB Leerink$22.00

Related

  • SEC1096d
    SEC Form EFFECT filed by Amryt Pharma plc
  • SEC1096d
    SEC Form 15F-12B filed by Amryt Pharma plc
  • SEC1096d
    SEC Form EFFECT filed by Amryt Pharma plc
  • SEC1096d
    SEC Form EFFECT filed by Amryt Pharma plc
  • SEC1101d
    SEC Form POS AM filed by Amryt Pharma plc
  • SEC1101d
    SEC Form POS AM filed by Amryt Pharma plc
  • SEC1101d
    SEC Form POS AM filed by Amryt Pharma plc
  • 13D/G1101d
    SEC Form SC 13G/A filed by Amryt Pharma plc (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022